SBP 101

Drug Profile

SBP 101

Alternative Names: SBP-101; SUN 101

Latest Information Update: 13 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Florida
  • Developer Sun BioPharma
  • Class Antineoplastics; Polyamines
  • Mechanism of Action Apoptosis stimulants; Caspase 3 stimulants; Cell division inhibitors; Poly(ADP-ribose) polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pancreatic cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Pancreatic cancer
  • Preclinical Pancreatitis

Most Recent Events

  • 01 Jun 2018 Safety, pharmacokinetics and efficacy data from phase I trial in Pancreatic cancer presented at 54th Annual Meeting of the American Society of Clinical Oncology (ASCO-2018)
  • 21 Mar 2018 Sun BioPharma announces intention to submit an application for orphan drug designation in Europe in the fourth quarter of 2018
  • 27 Feb 2018 US PTO accepts Sun BioPharma's provisional patent application for a novel manufacturing process for SBP 101
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top